bioAffinity Technologies (BIAFW) Treasury Shares (2022 - 2026)

bioAffinity Technologies has disclosed Treasury Shares across 5 years of filings, most recently posting $51810.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 96.7% year-over-year to $51810.0; the TTM figure through Mar 2026 stood at $51810.0 (down 96.7% YoY), while the FY2025 annual figure was $51810.0, up 17.06% from the prior year.
• Treasury Shares held at $51810.0 in Q1 2026, from $51810.0 in the prior quarter.
• Over the last five years, Treasury Shares for BIAFW reached as high as $1.6 million in Q1 2025 and fell as low as $44261.0 in Q4 2024.
• The 5-year median for Treasury Shares is $540969.0 (2023), against an average of $641512.2.
• Annual changes were most pronounced in 2023 — Treasury Shares surged 370.74% — and 2026, when it slumped 96.7%.
• A 5-year view of Treasury Shares shows it stood at $114920.0 in 2022, then jumped by 370.74% to $540969.0 in 2023, then slumped by 91.82% to $44261.0 in 2024, then gained by 17.06% to $51810.0 in 2025, then changed by 0.0% to $51810.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $51810.0, $51810.0, and $51849.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.